510(k) K032713
K032713 is an FDA 510(k) premarket notification submitted by Boston Biomedica, Inc. for the device "BOSTON BIOMEDICA, INC. BORRELIA BURGDORFERI IGM AND IGG". The FDA issued a decision of Substantially Equivalent on November 24, 2003. The device falls under product code LSR (Reagent, Borrelia Serological Reagent), a Class II device regulated under 21 CFR 866.3830. Boston Biomedica, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- November 24, 2003
- Date Received
- September 2, 2003
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Reagent, Borrelia Serological Reagent
- Device Class
- Class II
- Regulation Number
- 866.3830
- Review Panel
- MI
- Submission Type